BioRestorative Therapies
(NASDAQ) BRTX
BioRestorative Therapies Financials at a Glance
Market Cap
$8.98M
Revenue (TTM)
$357.87K
Net Income (TTM)
-$11.06M
EPS (TTM)
-$1.12
P/E Ratio
-0.31
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$0.37
Volume
3,183
Open
$0.37
Price
$0.37
Volume
3,183
Open
$0.37
Previous Close
$0.37
Daily Range
$0.35 - $0.38
52-Week Range
$0.16 - $1.89
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$0.37
Volume
3,183
Open
$0.37
Previous Close
$0.37
Daily Range
$0.35 - $0.38
52-Week Range
$0.16 - $1.89
Estimated Earnings Date
Aug 11, 2026
BRTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioRestorative Therapies
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Lance Alstodt
Website
www.biorestorative.comHeadquarters
Melville, NY 11747, US
BRTX Financials
Key Financial Metrics (TTM)
Gross Margin
92%
Operating Margin
-40%
Net Income Margin
-31%
Return on Equity
-241%
Return on Capital
-5%
Return on Assets
-2%
Earnings Yield
-3.23%
Dividend Yield
0.00%
Payout Ratio
-0.05%
Stock Overview
Market Cap
$8.98M
Shares Outstanding
25.48M
Volume
3.18K
Avg. Volume
10.88M
Financials (TTM)
Gross Profit
$335.86K
Operating Income
-$15.65M
EBITDA
-$14.03M
Operating Cash Flow
-$10.79M
Capital Expenditure
-$116.07K
Free Cash Flow
-$10.91M
Cash & ST Invst.
$2.95M
Total Debt
$0.00
BioRestorative Therapies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$23.17K
-7.3%
Gross Profit
$15.79K
-28.5%
Gross Margin
68.13%
N/A
Market Cap
$8.98M
N/A
Market Cap/Employee
$816.46K
N/A
Employees
11
N/A
Net Income
-$2.15M
+59.7%
EBITDA
-$2.15M
+59.3%
Quarterly Fundamentals
Total Cash
$3.59M
-60.6%
Total Debt
$0.00
N/A
Accounts Receivable
$13.30K
-46.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-2.38%
N/A
Return on Invested Capital
-4.70%
N/A
Free Cash Flow
-$3.81M
-35.3%
Operating Cash Flow
-$3.81M
-37.0%